In order to elucidate the relationship between COX-2 and tumor-associated VEGF expression, we first investigated the association of COX-2 expression in NSCLC tissue samples with clinical and pathologic factors, including VEGF expression and MVD. This evidence concerns the gene VEGFA and neoplasm.